CoChat

Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta‐analysis with meta‐regression

Giugliano, Dario, Bellastella, Giuseppe, Longo, Miriam, Scappaticcio, Lorenzo, Maiorino, Maria Ida, Chiodini, Paolo, Esposito, Katherine · 2020 · Diabetes, Obesity and Metabolism
Cited by 43

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Aim: In order to disclose relations between reduction of haemoglobin A1c (HbA1c) levels and risk of major cardiovascular events (MACE), we performed a meta‐analysis with metaregression of all cardiovascular outcome trials (CVOTs) so far published in patients with type 2 diabetes (T2D). Materials and Methods: An electronic search up to February 10, 2020 was conducted to determine eligible trials. Pooled summary estimates and 95% confidence intervals (CI) were calculated according to the random effects model using the Paule‐Mandel method; restricted maximum likelihood estimators were used to estimate model parameters in the metaregression. Results: The 15 CVOTs included evaluated 138,250 patients. In the pooled analysis, the risk of MACE was significantly reduced by 9% (hazard ratio, HR = 0.91, 0.87–0.95, P <0.001) as compared with placebo, with significant heterogeneity between trials ( I 2 = 44%, P = 0.060) There was a robust relation between the reduction in achieved HbA1c at the end of the trial and the HR reduction for MACE (beta = −0.3169, P = 0.029), explaining most (78%) of the between‐study variance; this relation was totally driven by the risk reduction of non‐fatal stroke only, which explained 100% of between‐study variance, and apparently restricted to the class of glucagon‐like peptide 1 receptor agonists (GLP−1RAs). There was no relation between the reduction in achieved HbA1c and the HR for heart failure (variance explained = 0%) or all‐cause mortality (variance explained = 6%). Conclusion: The blood glucose reduction observed in CVOTs may play some role in reducing the risk of non‐fatal stroke, at least during treatment with GLP‐1RAs, without affecting the other two components of MACE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.14047

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 43

Metadata

Authors
Giugliano, D., Bellastella, G., Longo, M., Scappaticcio, L., Maiorino, M. I., Chiodini, P., & Esposito, K.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2020-05-07
Volume
22
Issue
8
Pages
1397-1405
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W3014161033
Cited by
43
References
18
FWCI
5.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.